Amplatzer PFO

Optimal Outcomes Through Stroke Reduction

PATIENTS WHO CAN RECEIVE PFO OCCLUDERS

The PFO Occluder is indicated to reduce the risk of recurrent ischemic stroke in patients—predominantly between the ages of 18 and 60 years—who have had a cryptogenic stroke due to a presumed paradoxical embolism as determined by a neurologist and cardiologist following an evaluation to exclude known causes of ischemic stroke.

Among patients with a patent foramen ovale (PFO), the Amplatzer PFO Occluder has demonstrated excellent safety and efficacy in reducing the risk of recurrent stroke.

PFO Closure to Allay Patient Anxiety

For patients who have experienced cryptogenic stroke, the thought of a recurrence can generate anxiety. For patients’ peace of mind, the importance of determining and delivering the most effective treatment cannot be overemphasized.

  • Alan, grateful for PFO closure
  • Back to Walking 12 Miles per Day
    Alan Whitstable - England

    As an employee of the Royal Mail postal service “I’m back on full delivery, walking nearly 12 miles a day. Now it gets to be 8:00 at night and I’m still bouncing off the walls full of energy. I feel that I owe everyone who was involved a massive thank you.”

AP2947037-WBO Rev. A

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

Sign up

Receive updates from Abbott Structural Heart

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.